OBJECTIVE: To evaluate the efficacy and tolerance of a novel line treatment for periocular and perioral wrinkles. The line treatment was formulated with multiple growth factors, antioxidants, and a collagen-building peptide-ingredients that have been shown to increase collagen levels and provide long-term aesthetic benefits. To help provide immediate smoothing effects, hyaluronic acid filling spheres and a muscle contraction-inhibiting peptide were also included in the formulation. DESIGN: Three-month, single-center, open-label, clinical study with clinical assessments at Baseline, Minutes (within 15 minutes of initial application), Month 1, and Month 3. TREATMENT: Subjects treated periocular and perioral wrinkles twice daily for three months with the line treatment. PARTICIPANTS: Thirty-seven females, 33 to 45 years of age, with mild-to-moderate, fine and coarse periocular and perioral wrinkles, were enrolled in the study. MEASUREMENTS: Investigator assessments of fine and coarse periocular and perioral wrinkles, digital photography, and tolerance assessments were conducted at all visits. Subject self-assessment questionnaires were conducted within 15 minutes of initial application and at Month 3. RESULTS: Investigator assessments of both periocular and perioral wrinkles showed statistically significant improvements over Baseline within minutes of initial application; these positive findings continued to improve through Months 1 and 3 (all P</=0.0003). No treatment-related adverse events were reported. CONCLUSIONS: The results from this study demonstrate that this uniquely formulated line treatment was well tolerated and provided both immediate and long-term improvements in the appearance of fine and coarse wrinkles.
OBJECTIVE: To evaluate the efficacy and tolerance of a novel line treatment for periocular and perioral wrinkles. The line treatment was formulated with multiple growth factors, antioxidants, and a collagen-building peptide-ingredients that have been shown to increase collagen levels and provide long-term aesthetic benefits. To help provide immediate smoothing effects, hyaluronic acid filling spheres and a muscle contraction-inhibiting peptide were also included in the formulation. DESIGN: Three-month, single-center, open-label, clinical study with clinical assessments at Baseline, Minutes (within 15 minutes of initial application), Month 1, and Month 3. TREATMENT: Subjects treated periocular and perioral wrinkles twice daily for three months with the line treatment. PARTICIPANTS: Thirty-seven females, 33 to 45 years of age, with mild-to-moderate, fine and coarse periocular and perioral wrinkles, were enrolled in the study. MEASUREMENTS: Investigator assessments of fine and coarse periocular and perioral wrinkles, digital photography, and tolerance assessments were conducted at all visits. Subject self-assessment questionnaires were conducted within 15 minutes of initial application and at Month 3. RESULTS: Investigator assessments of both periocular and perioral wrinkles showed statistically significant improvements over Baseline within minutes of initial application; these positive findings continued to improve through Months 1 and 3 (all P</=0.0003). No treatment-related adverse events were reported. CONCLUSIONS: The results from this study demonstrate that this uniquely formulated line treatment was well tolerated and provided both immediate and long-term improvements in the appearance of fine and coarse wrinkles.
Authors: U Hoppe; J Bergemann; W Diembeck; J Ennen; S Gohla; I Harris; J Jacob; J Kielholz; W Mei; D Pollet; D Schachtschabel; G Sauermann; V Schreiner; F Stäb; F Steckel Journal: Biofactors Date: 1999 Impact factor: 6.113
Authors: W Bode; C Fernandez-Catalan; F Grams; F X Gomis-Rüth; H Nagase; H Tschesche; K Maskos Journal: Ann N Y Acad Sci Date: 1999-06-30 Impact factor: 5.691
Authors: P Brenneisen; J Wenk; L O Klotz; M Wlaschek; K Briviba; T Krieg; H Sies; K Scharffetter-Kochanek Journal: J Biol Chem Date: 1998-02-27 Impact factor: 5.157
Authors: Ignacio Mejía-Calvo; Leonardo E López-Juárez; Said Vázquez-Leyva; Carlos A López-Morales; Daniel Montoya-Escutia; Pamela G Merlos Rivera; José Enrique Herbert-Pucheta; Luis Gerardo Zepeda-Vallejo; Marco Velasco-Velázquez; Lenin Pavón; Sonia M Pérez-Tapia; Emilio Medina-Rivero Journal: J Cosmet Dermatol Date: 2020-05-10 Impact factor: 2.696